Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Sep 8, 2026
Reporting period
Not applicable
Filed with the SEC
Sep 10, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001420864-26-000022
Filed / recorded
Sep 10, 2026, 8:01 PM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
METLIFE INC
Issuer CIK
1099219
Ticker
MET
Reporting person
Daniel S Glaser
Relationship
Director
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Sep 8, 2026
Transaction code
A
Shares / units
10
Price per share
$95.50
Acquired / disposed
Acquired (A)
Shares owned after
2,705
Ownership form
Direct
Amendment
No
Footnotes from the filing
Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.